Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

On March 30, 2022, Alfred Altomari, the Chairman of the Board of Directors (the "Board") of Baudax Bio, Inc. (the "Company"), notified the Company of his intent to resign from the Board immediately following the Company's 2022 Annual Meeting of Shareholders (the "Annual Meeting"). On May 4, the Company held its Annual Meeting, but adjourned until May 18, 2022 at 9:00 A.M. Eastern Time to allow more time to establish a quorum.

In light of the adjournment of the Annual Meeting, Mr. Altomari updated his resignation to be effective as of May 4, 2022. Mr. Altomari's decision to resign did not result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices. The Company extends its deepest gratitude to Mr. Altomari for his distinguished service to the Board and lasting contributions to the Company.

In addition, effective on May 2, 2022, the Board appointed Mr. Wayne Weisman as the Chairman of the Board.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses